# Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab

> **NCT01405430** · NA · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 63 (actual)

## Conditions studied

- Colorectal Cancer
- Metastasis

## Interventions

- **BIOLOGICAL:** Bevacizumab + blood samples

## Key facts

- **NCT ID:** NCT01405430
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2015-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405430, "Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01405430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*